Clinical Care Options presents a new "Interactive Decision Support Tool" for Hepatitis B consultations to help determine whether and how to treat HBV patients, "Hep B Consult: US, European, and Asia-Pacific Guideline Recommendations on Whether and How to Treat HBV"
Downloading this tool is FREE but requires that you register with Clinical Care Options website:
https://www.clinicaloptions.com/hepatitis/programs/2019-hbv-management/idst/tool
Source: B
Friday, Jan 4, 2019
News Recap:
Hepatitis B Treatment, Viread, Approved in USA for Children Under 12
Hepatitis B in children is of particular concern, as the younger a person is when she/he contracts HBV, the greater likelihood of developing the chronic form of the disease. While HBV vaccination (primarily of users of IV drugs, or of infants born to HBV+ mothers) remains the greatest HBV-related public health challenge for Canada, we also should con...
Hepatitis B in children is of particular concern, as the younger a person is when she/he contracts HBV, the greater likelihood of developing the chronic form of the disease. While HBV vaccination (primarily of users of IV drugs, or of infants born to HBV+ mothers) remains the greatest HBV-related public health challenge for Canada, we also should consider the importance of treatment to our youngest victims of HBV. While this could involve a greater investm
Friday, Dec 7, 2018
News Recap:
Renally-Impaired Patients with Chronic Hepatitis B Virus Infection Find Success with Low Dose of TDF
A low dose of tenofovir disoproxil fumarate (TDF) may help to preserve renal function and maintain viral suppression in patients with chronic hepatitis B virus infection, even those with advanced liver disease, according to new research.
Join Us to Honour & Remember Our Friend Phil Wilkin
On Friday December 14,...
A low dose of tenofovir disoproxil fumarate (TDF) may help to preserve renal function and maintain viral suppression in patients with chronic hepatitis B virus infection, even those with advanced liver disease, according to new research.
TDF (Viread, Gilead) is currently approved for the treatment of chronic hepatitis B virus infection in adults and pediatric patients who are 12 years and older. Although the treatment is effective in inhibiting hepatitis
Friday, Nov 9, 2018
News Recap:
Gilead Presents Latest Data from Viral Hepatitis Research Programs at The Liver Meeting® 2018
Gilead Sciences announced results from studies investigating Epclusa in chronic HCV patients with severe renal impairment undergoing dialysis and Harvoni in pediatric HCV patients aged three to five years. As well there was data from Gilead’s HBV cure development program.
High Prevalence of Cirrhosis in Adults with Chronic...
SAN FRANCISCO--(BUSINESS WIRE)--Nov 9, 2018--Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from studies investigating Epclusa ® (sofosbuvir 400mg/velpatasvir 100mg) in chronic hepatitis C virus (HCV) infected patients with severe renal impairment undergoing dialysis and Harvoni ® (ledipasvir/sofosbuvir) in pediatric HCV patients aged three to five years, adding to the efficacy and safety profile of sofosbuvir-based regimens across diverse pa
Of adults with chronic hepatitis B virus (HBV) infection seen at a safety-net hospital, nearly 30% had cirrhosis at initial presentation, with older male patients being at the highest risk, according to a retrospective study published in the Journal of Clinical and Experimental Hepatology.
Cirrhosis is a serious consequence of HBV infection that is associated with a financial burden of $13 billion in the United States. Delays in HBV and cirrhosis diagnosi
Friday, Sep 21, 2018
News Recap:
New Chinese HBV Pamphlets from HepCBC
There are some new HBV pamphlets from HepCBC in Chinese: HBV Chinese (Traditional) and HBV Chinese (Simplified). View the rest of our new and recently updated pamphlets here: http://hepcbc.ca/publications/pamphlets-posters/
Events:
Tuesday, Sept. 25th approximately 11 am - 3 pm is the Downtown Eastside ALLEY Health Fair, location is intersection of Hastings and Columbia S...
Here are some new HBV pamphlets from HepCBC in Chinese (Traditional and Simplified)
HBV Chinese (Traditional)
HBV Chinese (Simplified)
View the rest of our pamphlets here: http://hepcbc.ca/publications/pamphlets-posters/
